Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Videos|May 30, 2023

CAR-T Cell Therapies Entering the Mainstream of Cancer Clinical Trials & Treatment

Author(s)Medidata

KEY LEARNING OBJECTIVES

  • Audience will have an understanding how Medidata can have an impact with Clinical Trial pharma and bio tech firms that are working in this therapeutic area
  • What are the challenges that CAR-T developers face and how can data help address those challenges
  • How is Medidata AI “data” different from other data providers


Related to this article

Better Site Training Starts With Five Simple Questions
Site training effectiveness depends on readiness at first-patient-in, requiring learning-science design principles around performance focus, cognitive load reduction, progressive sequencing, and spaced retrieval practice rather than training completion metrics or content volume.